Skip to content

General Discussion

A place to talk about whatever you want

12 Topics 32 Posts
The responses, guidance, and advisories provided by the Pharmaceutical Advertising Advisory Board (PAAB), including but not limited to those available through the PAAB Forum, the PAAB website, and any PAAB correspondences, are specifically intended to assist individuals navigating the PAAB preclearance system. Repurposing or reproducing this content without written consent from the PAAB Commissioner is strictly prohibited. This prohibition includes, but is not limited to, use in machine learning or AI models.
  • Product costs claims

    1
    0 Votes
    1 Posts
    16 Views
    No one has replied
  • XX-year product claim

    4
    0 Votes
    4 Posts
    188 Views
    L
    Thank you!
  • HCP-targeted ads in DTC spaces

    2
    0 Votes
    2 Posts
    40 Views
    Jennifer CarrollJ
    Hey @Maryssa Any ad which appears in the consumer space (even when limited through targeting based on interests or profession), are subject to the direct-to-consumer advertising regulations. Link to therapeutic use through study design, name, description, fair balance, or any other form, would not be acceptable since it would contravene Section C.01.044 of the Food and Drugs Act and Regulations which does not permit advertising of prescription medications to the general public beyond name, price and quantity.
  • Market research as a reference

    2
    0 Votes
    2 Posts
    48 Views
    Jennifer CarrollJ
    Hello @adelaidebaker Per Health Canada’s Terms and Conditions for Class B opioid products, advertising is restricted to messaging verbatim from the Health Canada approved Terms of Market Authorization. While “market research” and “claims” are broad and unclear, it is unlikely that market research can be used in advertising. If you have a specific case in mind, we invite you to submit for an opinion where additional context can be provided.
  • HCP "pro" website submission requirements

    3
    0 Votes
    3 Posts
    279 Views
    L
    @Jennifer-Carroll Thank you!
  • Pre-NOC storyboard review

    2
    0 Votes
    2 Posts
    424 Views
    Jennifer CarrollJ
    Hello @Jennifer-Thomson It sounds like this would fall under a PILOT: Administrative Guideline for the Review of Pre-NOC Advertising Submissions. We’d get the file to “no further comments” pending review of the layout (video) post NOC. Please reach out to admin to discuss the specifics so that we can ensure we’re understanding the request and facilitating the best possible pathway to approval.
  • Citing patient preference in a patient profile

    3
    0 Votes
    3 Posts
    292 Views
    A
    Hi @Jennifer-Carroll Thank you!
  • Product is "in stock" claim

    4
    0 Votes
    4 Posts
    469 Views
    Jennifer CarrollJ
    Hi @support A strictly informational statement about stock such as “Product X 5mg dose now back in stock” could be considered exempt. The inclusion of the indication statement renders it no longer exempt. The inclusion of a product photo MAY render it no longer exempt. This piece should likely be submitted for an exempt opinion to assess if the product photo can be used while meeting exempt criteria.
  • PAAB Code - Post hoc analysis

    2
    0 Votes
    2 Posts
    403 Views
    Jennifer CarrollJ
    Hello @msargeant Apologies for not seeing this question sooner. Per 3.1.1, post-hoc analysis are generally not considered acceptable evidence at this time. The circumstance in which post-hoc analyses would be considered acceptable is outlined in the statement that follows that copy which states “Data included in the TMA may be acceptable”. HTH.
  • Clarification on Product Available now! message in the APS

    3
    0 Votes
    3 Posts
    708 Views
    S
    Thank you @Jennifer-Carroll!
  • Clarification on indication inclusion in multi-Product APS

    5
    0 Votes
    5 Posts
    1k Views
    S
    Thank you @Jennifer-Carroll. This is very helpful!
  • Welcome to your NodeBB!

    1
    0 Votes
    1 Posts
    318 Views
    No one has replied
  • Healthcare Professional Tour

    1
    0 Votes
    1 Posts
    17k Views
    No one has replied
  • Industry Tour

    1
    0 Votes
    1 Posts
    7k Views
    No one has replied
  • Patient Tour

    1
    0 Votes
    1 Posts
    2k Views
    No one has replied
  • This topic is deleted!

    1
    0 Votes
    1 Posts
    100 Views
    No one has replied